3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Serotonin Syndrome
4
Neuroendocrine Tumors
4
Pancreatic Neoplasms
1
Diarrhea
1
Carcinoid Tumor
1
Carcinoid Heart Disease
1
Biliary Tract Neoplasms
1
Interventions
Octreotide
6
Irinotecan
6
Loperamide
5
Probiotics
3
Leucovorin
3
Fluorouracil
3
Fecal Microbiota Transplantation
3
Calcium Aluminosilicate
3
maltodextrin
2
telotristat ethyl
1
shosaiko-to
1
lanreotide
1
isatuximab
1
ceterizine hydrochloride
1
capivasertib
1
cabazitaxel
1
bile acid binding proteins
1
XRP6258
1
Theophylline
1
Temozolomide
1
Surveys and Questionnaires
1
Sulfasalazine
1
Sugars
1
Standard of Care
1
Raloxifene Hydrochloride
1
Radiation
1
Prednisone
1
PHY 906
1
Oxaliplatin
1
Long-Term Synaptic Depression
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Diarrhea
×
telotristat ethyl
×
Clear all
NCT04713202
2023-02-10
NET-PACS
Big Ten Cancer Research Consortium
Phase 2
Withdrawn